Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study

Hagop M. Kantarjian, Elias Jabbour, Nicholas J. Short et al.|The Lancet Oncology|2018

Cited by 242